Fresenius Medical Care AG & Co. KGaA FME

XET: FME | ISIN: DE0005785802   12/01/2026
40,64 EUR (+2,89%)
(+2,89%)   12/01/2026

9 januari 2026 · Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned · Persbericht

10 december 2025 · Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board · Persbericht

4 november 2025 · Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025 · Persbericht

30 oktober 2025 · Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025 · Persbericht

1 oktober 2025 · Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement · Persbericht

18 september 2025 · Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment · Persbericht

11 augustus 2025 · Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework · Persbericht

5 augustus 2025 · Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025 · Persbericht

31 juli 2025 · Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care · Persbericht

3 juli 2025 · Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico · Persbericht

17 juni 2025 · Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation · Persbericht

4 juni 2025 · Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S. · Persbericht

30 mei 2025 · Fresenius Medical Care presents its new research and innovation for kidney care at European Renal Association Congress 2025 · Persbericht

22 mei 2025 · Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History · Persbericht

6 mei 2025 · Fresenius Medical Care starts 2025 with strong organic revenue and income growth · Persbericht

13 maart 2025 · Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum · Persbericht

25 februari 2025 · Europees aandelennieuws · Bolero.be

Dormakaba verhoogt margevooruitzichten De Zwitserse beveiligingsgroep verhoogde haar jaarlijkse margevooruitzichten en zei dat een sterke orderportefeuille haar momentum in de tweede helft van het boekjaar 2024/2025 zou...

20 december 2024 · Europees aandelennieuws · Bolero.be

Amprion en Hitachi Energy tekenen contract oor Duitse converterstations De Zwitserse leverancier van energietechnologie en elektrificatie, meldde dat het contracten ter waarde van meer dan 2 miljard dollar heeft getekend...

4 september 2024 · Fresenius Medical Care Grows Number of U.S. Patients Using Company's Home Hemodialysis Machines, Launches NxStage® Versi®HD with GuideMe Software · Persbericht

30 juli 2024 · Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024 · Persbericht

Mijn selecties